Cisatracurium Besylate Injection
Product Images NDC 70436-114

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cisatracurium Besylate (NDC 70436-114). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

A scatter plot chart depicting percent change in heart rate (HR) on the vertical axis and mean arterial pressure (MAP) on the horizontal axis, each ranging from -60% to +60%. Individual data points are clustered near the origin, indicating variations in HR and MAP values.*

FDA Label Image

Figure 2 (Image 02)

A scatter plot chart depicting data points comparing percentage changes in Heart Rate (HR) on the vertical axis from -60% to +60%, and Mean Arterial Pressure (MAP) on the horizontal axis from -60% to +60%. The distribution of points appears centered around the origin with some spread indicating variability in both parameters.*

FDA Label Image

10 mg Per 5 mL Vial (Image 03)

Label for Cisatracurium besylate injection USP, 10 mg/mL strength, by Slate Run Pharmaceuticals, LLC. The label indicates a single-dose vial containing 5 mL and includes warnings about the paralytic agent causing respiratory arrest and instructions to discard unused portions. Storage and handling instructions are also visible.*

FDA Label Image

200 mg Per 20 mL (Image 04)

Label for Cisatracurium Besylate Injection USP 200 mg/20 mL (10 mg/mL) single-dose vial by Slate Run Pharmaceuticals, LLC. The label highlights the product as a paralyzing agent for intravenous use, marked For ICU use only. Storage instructions specify 2° to 8°C in the carton and usage within 21 days of removal from refrigeration.*

FDA Label Image

Chemical Structure (Image Structure)

Chemical structure of cisatracurium besylate, showing the molecular arrangement including quaternary ammonium groups, aromatic rings with methoxy substitutions, and the besylate counterion depicted separately.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.